èã®ããªãæ°ã«ãªãæ¹ãž
ã以åããèã®ããªããªããªã£ãŠããæ°ããããââããæããããšã¯ãããŸããããé¡ã®åã§é ¬ããã£ãšæã¡äžããŠé¢ãããšãã以åãšéãããã¿ãæãããã现ããªã·ã¯ãæ°ã«ãªã£ããããç¬éãããããšæããŸããã§ããããªããªã倱ãããã®ãããããŠå®éã«äœã广çãªã®ããããããããæŽçããæ å ±ã¯ãæå€ãšèŠã€ããã«ãããã®ã§ãã
ãã®èšäºã§ã¯ããœãŠã«æ±åã»ããµã³ããã®ã»ãªããã¯å»é¢(Cellinique)ã®ãã ã»ãŽã代衚é¢é·ããã«ãŠã³ã»ãªã³ã°ã§ã©ã®ããã«èã®ããªäœäžã®åå ã説æããŠãããããŸãæ¥åžžã±ã¢ãšæœè¡ãªãã·ã§ã³ãã©ã®ããã«çµã¿åãããŠæ€èšããŠããããã玹ä»ããŸããæœè¡ãªãã·ã§ã³ã«ãèå³ã®ããæ¹ã¯ããªãžã¥ã©ã³(Rejuran) vs. ãžã¥ãã«ãã¯(Juvelook) æ¯èŒã¬ã€ããã¹ãã³ããŒã¹ã¿ãŒæœè¡ã¬ã€ããããããŠã芧ãã ããã
3è¡ãµããªãŒ
1. èã®ããªãæ¯ããŠããã®ã¯çç®å ã®ã³ã©ãŒã²ã³ïŒType I ã 80ã90%ïŒãšãšã©ã¹ãã³ã§ãããã®2ã€ã®ã¿ã³ãã¯è³ªã¯ã20代äžç€ããMMPé µçŽ ã®æŽ»æ§äžæãšTGF-β ã·ã°ãã«ã®äœäžã«ãã£ãŠæ¯å¹Žå°ããã€æžå°ããŸãã
2. 玫å€ç·ïŒå èåïŒã¯ãã®ããã»ã¹ãäœåã«ãå éããå«ç ã»é飲ã»ç¡ç äžè¶³ãªã©ã®çæŽ»ç¿æ £ãé žåã¹ãã¬ã¹ãä»ããŠã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®åè§£ãä¿é²ããŸãã
3. ããªã®å埩ã«ã¯çŽ«å€ç·å¯ŸçãšçæŽ»ç¿æ £ã®æ¹åãåºç€ãšããåã ã®èç¶æ ã«å¿ããŠã¹ãã³ããŒã¹ã¿ãŒã»HIFUã»ãªãžã¥ã©ã³(Rejuran)ãªã©ã®æœè¡ãæ€èšããããšãã§ããŸããé©å¿ã«ã€ããŠã¯äºåã«ãŠã³ã»ãªã³ã°ã§å€æããŸãã
1. èã®ããªã®æ£äœ â ã³ã©ãŒã²ã³ãšãšã©ã¹ãã³
èã®ããªãçè§£ããã«ã¯ããŸãçç®ïŒdermisïŒãèŠãŠããå¿ èŠããããŸããçç®ã¯ç®èã®å€§éšåãå ããå±€ã§ãããã«ã³ã©ãŒã²ã³ïŒCollagenïŒãšãšã©ã¹ãã³ïŒElastinïŒãç·»å¯ãªç¶²ç®ç¶ã«çµ¡ã¿åã£ãŠããŸãã
ã³ã©ãŒã²ã³ïŒCollagenïŒ
ã³ã©ãŒã²ã³ã¯çç®ã®ä¹Ÿç¥ééã®70ã80%ãå ããäž»èŠæ§é ã¿ã³ãã¯è³ªã§ãããã®ãã¡Type I ã³ã©ãŒã²ã³ã80ã90%ãšæãå€ããType III ã8ã12%ãå ããŸããã³ã©ãŒã²ã³ç¹ç¶ã¯ç®èã«åŒåŒµåŒ·åºŠïŒtensile strengthïŒãããªãã¡åŒã£åŒµããããšãã«èããåãæäŸããŸãã
ãšã©ã¹ãã³ïŒElastinïŒ
ãšã©ã¹ãã³ã¯ãã®åã®ãšããã匟æ§ïŒelasticityïŒããæ ãã¿ã³ãã¯è³ªã§ããã³ã©ãŒã²ã³ãããéã¯ãã£ãšå°ãªãã§ãããå§åãåããåŸã«å ã®åœ¢ã«æ»ã埩å åïŒrecoilïŒã決å®ããéèŠãªæåã§ããã³ã©ãŒã²ã³ããèããåãã§ãããšããã°ããšã©ã¹ãã³ã¯ãæ»ãåããšãããŸãã
ã©ã¡ãã®ã¿ã³ãã¯è³ªãç®èç·ç¶èœçްèïŒfibroblastïŒã«ãã£ãŠç£çãããŸãããã®ãããç·ç¶èœçްèã®æ©èœãäœäžãããšäž¡æ¹ã®ã¿ã³ãã¯è³ªã®åæãæžå°ããŸãããããããªäœäžã®äžå¿çãªã¡ã«ããºã ã®ã²ãšã€ã§ãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå ž: PMC6540032 â Shin JW et al., Int J Mol Sci 2019ïŒãœãŠã«å€§åŠåå ç é¢ ç®èç§ïŒ
- çç®ã³ã©ãŒã²ã³ã®ãã¡Type I ã³ã©ãŒã²ã³ã80ã90%ãType III ã8ã12%ãå ããŸãã
- èåããç®èã§ã¯ MMP-1ãMMP-2ãMMP-3ãMMP-9 ãªã©ã®çºçŸãèããå¢å ããäžæ¹ããããæå¶ãã TIMP ã¯æ¯äŸçã«å¢å ãããã³ã©ãŒã²ã³åè§£ã®æ¹åã«ãã©ã³ã¹ãåŸããŸãã
- ç·ç¶èœçްèãåè§£ããã ECMïŒçްèå€ãããªãã¯ã¹ïŒãšã®çžäºäœçšã倱ããšãããå€ãã®æŽ»æ§é žçŽ ïŒROSïŒãç£çããèåãå éãããæ£ã®ãã£ãŒãããã¯ã«ãŒãã圢æãããŸãã
- å€åã®é床ã»çšåºŠã¯å人ã®èç¶æ ã»å¹Žéœ¢ã»çæŽ»ç¿æ £ã«ãã£ãŠç°ãªããŸãã
2. ããªã倱ãããçç± â å å æ§èå
ããªäœäžã®åå ã¯å€§ãã2ã€ã«åããããŸããã²ãšã€ç®ã¯å å æ§èåïŒintrinsic agingïŒãããªãã¡æéã®çµéãšãšãã«èªç¶ã«çããå€åã§ãã
MMP 掻æ§ã®äžæ + TGF-β ã·ã°ãã«ã®äœäž
å 霢ã«äŒŽããç®èã®ç·ç¶èœçްèã«ãããŠåºè³ªéå±ãããã¢ãŒãŒïŒMMPãmatrix metalloproteinaseïŒã®çºçŸãå¢å ããŸããMMP ã¯ã³ã©ãŒã²ã³ç¹ç¶ãåæã»åè§£ããé µçŽ ã§ããåæã«ãã³ã©ãŒã²ã³åæãä¿é²ããTGF-βïŒãã©ã³ã¹ãã©ãŒãã³ã°æé·å åããŒã¿ïŒã·ã°ãã«çµè·¯ã掻æ§é žçŽ ïŒROSïŒã®åœ±é¿ãåããŠåŒ±ãŸããŸããçµæãšããŠãç£çã¯æžããåè§£ã¯å¢ããããšããã¢ã³ãã©ã³ã¹ãçããŸãã
ç·ç¶èœçްèã®èå
ç·ç¶èœçްèèªäœãèåããæ°ãæžå°ããŠæ©èœãäœäžããŸãããã§ã«åè§£ããã ECM ãšã®æ¥è§Šãæžãããšã§çްèãåçž®ããããå€ãã® ROS ãç£çããããã«ãªããŸãããã® ROS ãããã« TGF-β ã·ã°ãã«ãé»å®³ããŠã³ã©ãŒã²ã³åæãäœäžããããšããæªåŸªç°ãç¶ããŸãã
ãšã©ã¹ãã³ã®å€å
å å æ§èåã§ã¯ããã£ããªãªã³ïŒfibrillinïŒã«å¯ãã 埮å°åç¹ç¶ïŒmicrofibrilïŒãéžæçã«åè§£ãããæ©èœçãªåŒŸæ§ç¹ç¶ã®å«éãæžå°ããŸããã匵ãããä¿ã€æ§é äœãåŸã ã«åŒ±ãŸã£ãŠãããŸãã
| æ§æèŠçŽ | äž»ãªå€å | çµæ |
|---|---|---|
| Type I ã³ã©ãŒã²ã³ | MMP å¢å + TGF-β ã·ã°ãã«äœäž â åè§£å éã»åæäœäž | åŒåŒµåŒ·åºŠã®äœäžãç®èã®è²èå |
| ãšã©ã¹ãã³ | ãã£ããªãªã³åŸ®å°åç¹ç¶ã®åè§£ã匟æ§ç¹ç¶æ©èœã®äœäž | 埩å åïŒrecoilïŒã®äœäžãããã¿ |
| ç·ç¶èœçްè | æ°ã®æžå°ã»æ©èœäœäžãROS éå°ç£çãã£ãŒããã㯠| ã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³åæèœåã®äœäž |
| GAGã»ãã¢ã«ãã³é ž | ãã¢ã«ãã³é žçµåã¿ã³ãã¯ã®æžå°ãæ°Žåä¿æåã®äœäž | ç®èã®ããªã¥ãŒã æã»ããªæã®äœäž |
3. ããªãæãéãäœäžããããã® â å èåïŒPhotoagingïŒ
å å æ§èåããã£ãããšé²è¡ããã®ã«å¯Ÿããå èåïŒphotoagingïŒã¯åãããã»ã¹ãã¯ããã«éãé²è¡ãããŸãã玫å€ç·ïŒUVïŒãç®èã«åœãããšãç®è现è衚é¢ã®å容äœã掻æ§åããé£éçãªã·ã°ãã«çµè·¯ãå§ãŸããŸãã
UV ãç®èãèåãããçµè·¯
玫å€ç·ç §å° â æŽ»æ§é žçŽ ïŒROSïŒã®ç£ç â MAPKã»NF-κB çµè·¯ã®æŽ»æ§å â AP-1 転åå åã®çºçŸ â MMP çºçŸã®æ¥å¢ â ã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®åè§£å éããããå èåã®æ žå¿çãªååçµè·¯ã§ãã
UVA ã¯å€ªéœå 玫å€ç·ã®çŽ95%ãå ããçç®ã®æ·±éšãŸã§æµžéããŠã³ã©ãŒã²ã³ãšãšã©ã¹ãã³ãçŽæ¥æå·ããŸããUVB ã¯å²åã¯å°ãªãã§ãããUVA ãããçç©åŠç掻æ§ãã¯ããã«é«ãã衚ç®ã® DNA æå·ãåŒãèµ·ãããŸãã
æ¥å æ§åŒŸæ§ç·ç¶çïŒSolar ElastosisïŒ
æ ¢æ§çãªçŽ«å€ç·æé²ã®ä»£è¡šçãªçµæãæ¥å æ§åŒŸæ§ç·ç¶çïŒsolar elastosisïŒã§ããæ£åžžã«æŽåãã匟æ§ç¹ç¶ã®ä»£ããã«ãæ©èœããªãç°åžžãªåŒŸæ§ç©è³ªãèç©ããç¶æ ã§ããMMP-12 ãæŽ»æ§åãããããšã§æ¢åã®åŒŸæ§ç¹ç¶ãåè§£ãããæ£åžžã«çµã¿ç«ãŠãããŠããªãäžèŠåãªåŒŸæ§ç©è³ªãå ç©ããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå ž: PMC8802961 â Chen X et al., Postepy Dermatol Alergol 2022 · PMID 27731897 â Weihermann AC et al., Int J Cosmet Sci 2017
- 玫å€ç·ã ROS ãç£çããMAPKã»NF-κB çµè·¯ãéããŠMMP çºçŸãå¢å ãããã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ãåè§£ããã¡ã«ããºã ã確èªãããŠããŸãã
- å èåã§ã¯MMP-12 ã®æŽ»æ§åã«ãã£ãŠç°åžžã»éæ©èœçãªåŒŸæ§ç¹ç¶ç©è³ªãèç©ããæ¥å æ§åŒŸæ§ç·ç¶çïŒsolar elastosisïŒãçããŸãã
- UV ç §å°ã«ãããšã©ã¹ãã³éºäŒåã®ç°åžžã¹ãã©ã€ã·ã³ã°ïŒalternative splicingïŒã匟æ§ç¹ç¶ã®çµã¿ç«ãŠã«å¿ èŠãªã¿ã³ãã¯è³ªåæã劚ããå¯èœæ§ã瀺ãååçæ ¹æ ã瀺ãããŠããŸãã
- é²è¡ã®çšåºŠã¯å人ã®èç¶æ ã»æ¥åžžçãªçŽ«å€ç·æé²éã«ãã£ãŠç°ãªããŸãã
4. çæŽ»ç¿æ £ãããªãäœäžãããŸã
玫å€ç·ä»¥å€ã«ããæ¥åžžã®çæŽ»ç¿æ £ãããªã®äœäžãå éãããããšããããŸãããããã®å ±éçµè·¯ããã¯ãé žåã¹ãã¬ã¹ã§ãã
å«ç
æ ¢æ§å«ç è ã®ç®èã®ããã®ãã¿ãŒã³ããæ°å幎幎äžã®éå«ç è ãšé¡äŒŒããç¶æ ã瀺ãå Žåããããšããå ±åããããŸãããã°ãã®ç ã«å«ãŸããæåã ROS ãç£çããMMP ãæŽ»æ§åããŠã³ã©ãŒã²ã³åè§£ãä¿é²ããŸããè¡ç®¡åçž®ã«ããæ é€äŸçµŠã®äœäžãç·ç¶èœçްèã®æ©èœã«åœ±é¿ãäžããŸãã
é飲
é床ã®ã¢ã«ã³ãŒã«æåãé¡é¢ã®ããã®å¢å ãè¡ç®¡å¯åºŠã®äœäžãšé¢é£ãããšããç ç©¶çµæããããŸããçŽæ¥çãªè±æ°Žå¹æã«å ããé žåã¹ãã¬ã¹çµè·¯ãéããŠç®èã®æ§é ã¿ã³ãã¯è³ªã«ã圱é¿ãäžããŸãã
ç¡ç äžè¶³ã»æ ¢æ§ã¹ãã¬ã¹
ç¡ç äžã¯ç®èã®å埩ã»åçããã»ã¹ã掻çºã«è¡ãããŸããç¡ç ãäžè¶³ãããšã³ã«ããŸãŒã«å€ãäžæããŠã³ã©ãŒã²ã³åæãé»å®³ããç®èããªã¢æ©èœãäœäžããå¯èœæ§ããããŸããæ ¢æ§ã¹ãã¬ã¹ãåãçµè·¯ã§äœçšããŸãã
é£äºã»æ é€
ã³ã©ãŒã²ã³åæã«ã¯ãã¿ãã³ C ãäžå¯æ¬ ã§ãããã¿ãã³ C ã¯ãããªã³ã»ãªã·ã³æ®åºã®æ°Žé žååå¿ã«é¢äžããè£é µçŽ ã§ãããæ¬ ä¹ãããšæ£åžžãªã³ã©ãŒã²ã³äžéãããæ§é ã®åœ¢æã«æ¯éãçããŸããæé žåæ é€çŽ ã®æåãäžè¶³ãããšãROS ã«ããã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®æå·ãé²ãããšãé£ãããªããŸãã
5. ãã«ã¢ã³å€åãšããª
ããªã®äœäžã¯åçŽã«ã幎霢ã®åé¡ãã§ã¯ãªãããã«ã¢ã³å€åãšã坿¥ã«é¢ä¿ããŠããŸããç¹ã«éçµåŸã«ãšã¹ããã²ã³ãäœäžãããšãç®èå ã®ã³ã©ãŒã²ã³éãæ¥æ¿ã«æžå°ããããšããããŸãã
çµç¹å ã®ã³ã©ãŒã²ã³æžå°ã¯ãå®éã®æŠå¹Žéœ¢ïŒchronologic ageïŒãããéçµåŸã®çµéæéãšãã匷ãçžé¢é¢ä¿ã瀺ããšããå ±åããããŸããéçµåŸã®ãšã¹ããã²ã³äœäžã¯ãç®èã®ããã»ä¹Ÿç¥ã»èçž®ã»ããã¿ãããã«å·ã®å埩é å»¶ã«ã圱é¿ããããšãç¥ãããŠããŸãããã®ãã30ã50代ã®å¥³æ§ãããªã®äœäžãæ¥æ¿ã«æããã±ãŒã¹ãå€ãã¿ãããŸãã
6. ããªå埩ã®ã¢ãããŒã â æ¥åžžã±ã¢ãã
ããªã倱ãããåå ãè€åçã§ãã以äžãå埩ã®ã¢ãããŒããåºç€ãšãªãæ¥åžžã±ã¢ãæ¬ ããããšã¯ã§ããŸãããã©ã®ãããªæœè¡ãåãããšããŠãã玫å€ç·å¯ŸçãšçæŽ»ç¿æ £ã®æ¹åããªããã°å¹æãçžæ®ºãããŠããŸããŸãã
玫å€ç·å¯Ÿç â æãæ ¹æ ã確ããªèåäºé²
å èåã®ã¡ã«ããºã ãèŠããšã玫å€ç·å¯Ÿçãèã®ããªç¶æã«æãæ ¹æ ã®ç¢ºããªäºé²çã±ã¢ã§ããããšãããããŸããSPF 30 以äžã»PA+++ 以äžã®æ¥çŒãæ¢ããæ¯æ¥ã宀å ã§ã䜿çšããããšãåºæ¬ã§ãã
ã¬ããã€ãïŒRetinoidsïŒ
屿å¡åžã®ã¬ããã€ãã¯ãType Iã»IIIã»VII ã³ã©ãŒã²ã³ãå¢å ãããMMP ãæžå°ããã匟æ§ç¹ç¶ãåæ§æãã广ãèšåºç ç©¶ã§å ±åãããŠããŸããå»åž«ã®æå°ã®ããšé©åãªæ¿åºŠããéå§ããããšãæšå¥šãããŸãã
ãã¿ãã³ C
屿ãã¿ãã³ C 㯠ROS é€å»å€ãšããŠäœçšãããšãšãã«ãã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³çåæã®è£å©å åã§ããããŸããåžåçã®é«ãå®å®å補å€ãéžã¶ããšãéèŠã§ãã
é£äºã»ç掻ãã¿ãŒã³
æé žåé£åã®æåãååãªæ°Žåè£çµŠãç¡ç ã®è³ªã®ç®¡çãçŠç ã»ç¯é ã¯æ¥åžžã±ã¢ã®æ±ã§ãããããã¯ããªç®¡çã«ãããŠãè²»çšå¯Ÿå¹æã®é«ããåãçµã¿ãšãããŸãã
7. æœè¡ãªãã·ã§ã³ã®æŠèг â åã¢ãããŒãã®ã¡ã«ããºã ãšå人差
æ¥åžžã±ã¢ãåºç€ãšããŠãå人ã®èç¶æ ãšç®æšã«å¿ããŠæœè¡ãæ€èšããããšããããŸããæœè¡ã¯æ ¹æ¬çã«ç®èèªèº«ã®åçã¡ã«ããºã ãæŽ»æ§åãããããæ§é ãæ¹åããæ¹åã«åããŸãã以äžã¯äžè¬çãªæœè¡ãªãã·ã§ã³ã®æŠèгã§ãããã©ã®æœè¡ãå®éã«é©åãã¯å¿ ãäºåã«ãŠã³ã»ãªã³ã°ã§å人ã®ç¶æ ã確èªããäžã§æ±ºå®ããŸãã
| æœè¡ã¿ã€ã | äž»ãªã¡ã«ããºã | äž»ãªç¹åŸŽ | åäººå·®ã»æ³šæç¹ |
|---|---|---|---|
| HIFU / ãŠã«ã»ã© ïŒé«å¯åºŠçŠç¹åŒè¶ 鳿³¢ïŒ |
è¶ é³æ³¢ãšãã«ã®ãŒã§çç®ã»SMAS å±€ã«ç±åºæ¿ â ã³ã©ãŒã²ã³ã®åçž®ã»åçãèªå° | ããŠã³ã¿ã€ã å°ããªããã£ã³ã°æ¹å | å¹æã»æç¶æéã®å人差ã倧ãããé©å¿ã»å¯äœçšã¯ã«ãŠã³ã»ãªã³ã°ã§ç¢ºèª |
| ã¹ãã³ããŒã¹ã¿ãŒ ïŒãžã¥ãã«ãã¯(Juvelook)ã»HA ç³»ïŒ |
çç®å ãžã®æåæ³šå ¥ã§æ°Žåã»ããªã¥ãŒã è£å ãã³ã©ãŒã²ã³åºæ¿ïŒè£œåã«ããã¡ã«ããºã ç°ãªãïŒ | 峿çãªæœ€ãæãæ¯èŒçèªç¶ãªå€å | é©åãªæåã»åæ°ã»çµã¿åããã¯ã«ãŠã³ã»ãªã³ã°ã§æ±ºå® |
| ãªãžã¥ã©ã³(Rejuran)ïŒPNïŒ ïŒããªãã¯ã¬ãªããïŒ |
PN ãç®èã®åçã»ECM å埩ãä¿é²ããã³ã©ãŒã²ã³åæã«é¢é£ãã现èåå¿ãèªå° | åçäžå¿ãè質æ¹åã®æ¹å | 广ã®çšåºŠã»é床ã«å人差ãããåºå ž: éåœé£åå»è¬åå®å šåŠ(MFDS)æ¿èªè£œå |
| ã¬ãŒã¶ãŒã»RF ïŒãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒã»é«åšæ³¢ïŒ |
çç®å ç± â ã³ã©ãŒã²ã³ã®åçž®ã»ECM ãªã¢ããªã³ã° â æ°çã³ã©ãŒã²ã³åæ | è質ã»ããªæ¹åãããŠã³ã¿ã€ã ã¯è£œåã«ããç°ãªã | èã¿ã€ãã»è²çŽ ç¶æ ãªã©å人æ¡ä»¶ãéèŠ |
| 屿ã¬ããã€ã ïŒåŠæ¹ïŒ |
Type Iã»IIIã»VII ã³ã©ãŒã²ã³å¢å ãMMP æžå°ã匟æ§ç·ç¶ã®åæ§æ | åŠæ¹ãå¿ èŠãé·æäœ¿çšæã«èšåºçæ ¹æ ãã | ç®èåºæ¿ã»å éææ§ã®å¯èœæ§ãããå»åž«æå°ã®ããšäœ¿çš |
ð¡ ãã¡ã¯ããã§ã㯠â
åºå ž: PMC10527789 â Oh S et al., Cells 2023ïŒHIFU ã¡ã«ããºã ïŒÂ· PMC6540032 â Shin JW et al., Int J Mol Sci 2019ïŒã¬ããã€ãã»RF ã®æ ¹æ ïŒ
- HIFU 㯠2023 幎ã®çްèç ç©¶ã«ãããŠã«ããªãªã³-1ïŒCav-1ïŒã®çºçŸãäœäžãããERK1/2 ãªã³é žåãå¢å ãããç·ç¶èœçްèã®å¢æ®ãšType Iã»III ã³ã©ãŒã²ã³ããã³ãšã©ã¹ãã³ã®åæãä¿é²ããã¡ã«ããºã ã確èªãããŸããã
- ã¬ããã€ã㯠Type Iã»IIIã»VII ã³ã©ãŒã²ã³ã®å¢å ãMMP ã®æžå°ã匟æ§ç¹ç¶ã®åæ§æå¹æãèšåºç ç©¶ã§å ±åãããŠããŸãã
- ãã©ã¯ã·ã§ãã«ã¬ãŒã¶ãŒãšé«åšæ³¢ïŒRFïŒãçç®å ç±ã«ãã Type Iã»III ããã³ã©ãŒã²ã³åæå¢å 广ãå ±åãããŠããŸãã
- ãã¹ãŠã®æœè¡ã¯é©å¿ã»å¯äœçšã®å¯èœæ§ã»æåŸ ãããçµæãå人ã®èç¶æ ã«ãã£ãŠç°ãªããäžæŠã«ã¯èšããªããããäºåã«ãŠã³ã»ãªã³ã°ã§æ±ºå®ããŸãã
8. ã»ãªããã¯å»é¢(Cellinique)ã®ã¢ãããŒã
æ±åããµã³ããã®ã»ãªããã¯å»é¢(Cellinique)ã§ã¯ãããªã®äœäžã«ã€ããŠãçžè«ã«æ¥ãããæ¹ã«å¯ŸãããŸãèç¶æ ã®è©äŸ¡ãšåå ã®ææ¡ããå§ããŸãããã©ã®æœè¡ããã¬ã³ãããã§ã¯ãªããããã®æ¹ã®ããªäœäžã¯å å æ§èåãäž»äœãªã®ããå èåã®åœ±é¿ã倧ããã®ããçæŽ»ç¿æ £äžã®èŠå ãããã®ãããæåã«ç¢ºèªããã¢ãããŒãã§ãã
ãã ã»ãŽã代衚é¢é·ã¯ååã«ãŠã³ã»ãªã³ã°ããæœè¡ã»ã¢ãã¿ãŒã±ã¢ãŸã§çŽæ¥æ åœããã²ãšã€ã®æœè¡ã«ãã ããã®ã§ã¯ãªããæ¥åžžã±ã¢ãåºç€ãšããŠæœè¡ãªãã·ã§ã³ãçµã¿åãããèšèšãéèŠããŠããŸããæœè¡ãè¡ããã©ãããæœè¡ã®çš®é¡ãçµã¿åããæ¹ã¯ã«ãŠã³ã»ãªã³ã°ã§åã ã®ç¶æ ã確èªããäžã§æ±ºå®ãããã¹ãŠã®æ¹ã«åãçµæããçŽæããããšã¯ã§ããŸããã
ãããã質åïŒFAQïŒ
Q1. èã®ããªã¯ããã€ãã倱ããå§ããŸããïŒ
å人差ã¯ãããŸãããã³ã©ãŒã²ã³åæãåŸã ã«äœäžããå€åã¯20代äžç€ããåŸåã«å§ãŸããšèšãããŠããŸãããã ãã宿ãšããŠæ°ã«ãªãå§ããææã¯äººã«ãã£ãŠç°ãªããŸãã玫å€ç·ãžã®æé²ãå€ãæ¹ããå«ç ã»ç¡ç äžè¶³ãªã©ã®çæŽ»ç¿æ £äžã®èŠå ãããæ¹ã¯ãããæ©ãææã«çŸããããšããããŸããããªäœäžã®éåºŠãæ§çžã«ãå人差ããããŸãã
Q2. ã³ã©ãŒã²ã³ãµããªã飲ããšèã®ããªãå埩ããŸããïŒ
çµå£ã³ã©ãŒã²ã³æåã«ã€ããŠã¯ãäžéšã®ç ç©¶ã§ç®èã®æ°Žåã»åŒŸåææšã®æ¹åãå ±åãããŠããŸãããèšåºçãšããã³ã¹ã®ã¬ãã«ãšèŠæš¡ã¯ãŸã æ§ã ã§ããæåããã³ã©ãŒã²ã³ããã®ãŸãŸç®èã®ã³ã©ãŒã²ã³ã«ãªãããã§ã¯ãªããæ¶åã®éçšã§ã¢ããé žã»ãããããšããŠåžåãããåŸãæ§ã ãªçµè·¯ã§äœçšããŸããå ·äœçãªå¹æãšé©åæ§ã«ã€ããŠã¯å»åž«ã«çžè«ããŠæ±ºããããšããå§ãããŸãã
Q3. æ¥çŒãæ¢ãã¯å®€å ã§ãå¡ãå¿ èŠããããŸããïŒ
宀å ã§ãçªãéã㊠UVA ãééããŸããUVA ã¯ã¬ã©ã¹ãééããããã宀å ç°å¢ã§ãå®å šã«ã¯é®æãããŸãããç¹ã«çªéã§é·æéäœæ¥ããããè»ã®é転æéãé·ãæ¹ã¯ã宀å ã§ãæ¥çŒãæ¢ãã䜿çšããããšãå èåäºé²ã®èгç¹ããæšå¥šãããŸãã
Q4. ããªäœäžã«ã¯ã¹ãã³ããŒã¹ã¿ãŒãš HIFU ã®ã©ã¡ããåããŠããŸããïŒ
2ã€ã®æœè¡ã¯äœçšã®æ¹åãç°ãªããŸããã¹ãã³ããŒã¹ã¿ãŒã¯çç®å ãžã®æ°Žåã»æ é€è£çµŠãšæåã«ããã³ã©ãŒã²ã³åºæ¿ã«çŠç¹ãåœãŠãHIFU ã¯æ·±ãå±€ãŸã§è¶ 鳿³¢ãšãã«ã®ãŒãäŒéããŠãªããã£ã³ã°ã»ã³ã©ãŒã²ã³åçãèªå°ããæ¹åã§ããã©ã¡ããé©ããŠãããã¯ãããªäœäžã®æ§çžã»éšäœã»çšåºŠã»ä»ã®æœè¡ãšã®çµã¿åããã«ãã£ãŠç°ãªããŸããåã ã®ç¶æ ã«åã£ãéžæã¯äºåã«ãŠã³ã»ãªã³ã°ã§ã®ã¿æ±ºå®ã§ããŸãã
Q5. ããªç³»ã®æœè¡åŸã广ã¯ã©ã®ãããæç¶ããŸããïŒ
æœè¡ã®çš®é¡ã»å人ã®èç¶æ ã»çæŽ»ç¿æ £ã«ãã£ãŠæç¶æéãç°ãªããŸãããããªãæœè¡ãæ°žç¶çã§ã¯ãªãã玫å€ç·å¯Ÿçãšç掻ã±ã¢ã䞊è¡ãããã©ãããæç¶æéã«åœ±é¿ããŸããåæœè¡ã®æ³å®ãããæç¶æéã¯ã«ãŠã³ã»ãªã³ã°ã§åã ã®ç¶æ ã確èªããäžã§ãæ¡å ããŸããäžè¬çãªæ°å€ãæå®ããããšãé£ããçç±ãããã«ãããŸãã
Q6. ã³ã©ãŒã²ã³æ³šå°ãæãŠã°ããã«ããªãæ»ããŸããïŒ
ãã³ã©ãŒã²ã³æ³šå°ããšãã衚çŸã¯æœè¡ã®çš®é¡ã«ãã£ãŠæå³ãç°ãªããŸãããã£ã©ãŒã®ããã«å€éšã®ç©è³ªã§ããªã¥ãŒã ãè£ãæ¹æ³ãããã°ãã¹ãã³ããŒã¹ã¿ãŒãªã©ç®èèªèº«ã®åçãå©ããæ¹æ³ããããŸããã©ã¡ãã峿çãªããªã®å埩ãä¿èšŒãããã®ã§ã¯ãªããæœè¡ã®ç¹æ§ãšå人ã®ç¶æ ã«ãã£ãŠäœæã®ä»æ¹ãç°ãªããŸããã©ã®ã¢ãããŒããåã£ãŠãããã¯ã«ãŠã³ã»ãªã³ã°ã§ååã«ãçžè«ãã ããã
Q7. ããªç®¡çã§æã倧åãªããšãã²ãšã€æãããšãããïŒ
玫å€ç·å¯Ÿçã§ããå èåã®ååã¡ã«ããºã ãæããã«ãªãã«ã€ãã玫å€ç·ãã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³ã®åè§£ãå éããäž»èŠãªå€å æ§èŠå ã§ããããšãç¹°ãè¿ã確èªãããŠããŸããã©ã®ãããªæœè¡ãã±ã¢ãè¡ã£ãŠãã玫å€ç·å¯Ÿçãªãã§ã¯å¹æãæ©ãçžæ®ºãããŠããŸããŸããSPFã»PA ææ°ã«åã£ãæ¥çŒãæ¢ããæ¯æ¥äœ¿çšããããšãæã確ããªäºé²çã±ã¢ã§ãã
Q8. ã«ãŠã³ã»ãªã³ã°ã¯ã©ã®ããã«å§ããã°ããã§ããïŒ
æœè¡ãããã«æ±ºããå¿ èŠã¯ãããŸãããçŸåšã®èã®ç¶æ ããæ©ã¿ããŸãã話ãããã ãã«ãŠã³ã»ãªã³ã°ããã¹ã¿ãŒãããŠããã ããŸããã»ãªããã¯å»é¢(Cellinique)㯠02-6203-3434 ãŸãã¯ã«ã«ãªããŒã¯ã§ãæ°è»œã«ãåãåããããã ããŸããã«ãŠã³ã»ãªã³ã°ã»æœè¡ã®è²»çšã¯å人ã®ç¶æ ã»èšèšã«ãã£ãŠç°ãªããŸãã®ã§ãã«ãŠã³ã»ãªã³ã°æã«ãæ¡å ããŸãã
ãŸãšã
èã®ããªäœäžã¯åäžã®åå ã§ã¯ãªããå å æ§èåã»å èåã»çæŽ»ç¿æ £ã»ãã«ã¢ã³å€åãè€åçã«äœçšããçµæã§ããMMP 掻æ§ã®äžæã«ããã³ã©ãŒã²ã³ãåè§£ãããTGF-β ã·ã°ãã«ã匱ãŸããç·ç¶èœçްèã®æ©èœãäœäžããæµããæ ¹åºã«ããã玫å€ç·ãããã倧ããå éãããŸãã
ãã®ãããããªå埩ã®åºçºç¹ã¯æŽŸæãªæœè¡ããã玫å€ç·å¯Ÿçãšæ¥åžžã±ã¢ã§ãããã®äžã§åã ã®èç¶æ ã«åã£ãæœè¡ãªãã·ã§ã³ãæ€èšããã®ãæ£ããé åºã§ããã©ã®æ¹æ³ãèªåã«åã£ãŠãããã¯äžã€ã®çããããããã§ã¯ãªããã«ãŠã³ã»ãªã³ã°ã§çŽæ¥ç¢ºèªããªããã°ããããŸããã
ã»ãªããã¯å»é¢(Cellinique)ïŒæ±åã»ããµã³ããïŒã§ã¯ããã ã»ãŽã代衚é¢é·ãããªäœäžã®åå ææ¡ããæ¥åžžã±ã¢ã®ã¢ããã€ã¹ãæœè¡ã®æ€èšãŸã§çŽæ¥ãçžè«ãæ¿ããŸããããªã®äœäžãæ°ã«ãªãæ¹ã¯ããŸãã«ãŠã³ã»ãªã³ã°ã§ã話ãããã ãããšããå§ãããŸããã¹ãã³ããŒã¹ã¿ãŒã®ãªãã·ã§ã³ã¯ãªãžã¥ã©ã³(Rejuran) vs. ãžã¥ãã«ãã¯(Juvelook) æ¯èŒã¬ã€ãã§ãæœè¡ã®ãæ¡å ã¯ã¹ãã³ããŒã¹ã¿ãŒæœè¡ã¬ã€ãã§ã確èªããã ããŸãã
å¹æã»æç¶ã»é©åæ§ã¯å人ã®èç¶æ ã»å¹Žéœ¢ã»çæŽ»ç¿æ £ã«ãã£ãŠç°ãªããåäžã®çµæãä¿èšŒããããšã¯ã§ããŸããã
æœè¡ã«ã¯äžæçãªçŽ æã»æµ®è «ãªã©ã®å¯äœçšã®å¯èœæ§ããããçŠå¿äºé ãããå ŽåããããŸãã®ã§ãäºåã«ãŠã³ã»ãªã³ã°ã«ãŠã確èªãã ããã
â ãã¡ã¯ããã§ãã¯å®äºã¬ããŒã
ãã®èšäºã®äž»èŠãªå»çã»ç§åŠæ å ±ã¯ä»¥äžã®åºå žã§ç¢ºèªããŸããã
- PMC6540032 · PMID 31036793 â Shin JW et al., "Molecular Mechanisms of Dermal Aging and Antiaging Approaches", Int J Mol Sci 2019ïŒãœãŠã«å€§åŠåå ç é¢ ç®èç§ïŒâ Type I ã³ã©ãŒã²ã³ 80ã90%ãMMP å¢å ãTGF-β ã·ã°ãã«äœäžãç·ç¶èœçްèã®èåããšã©ã¹ãã³å€åãGAG å€åãã¬ããã€ãã»ã¬ãŒã¶ãŒã»RF ã®æ ¹æ
- PMC8802961 · PMID 35125996 â Chen X et al., "Research progress on skin photoaging and oxidative stress", Postepy Dermatol Alergol 2022 â å èåã®ååçµè·¯ïŒROS â MAPKã»NF-κB â MMPïŒãUVA 95% æ§æãUVB çç©åŠç掻æ§ãæ¥å æ§åŒŸæ§ç·ç¶çïŒsolar elastosisïŒ
- PMID 27731897 â Weihermann AC et al., "Elastin structure and its involvement in skin photoageing", Int J Cosmet Sci 2017 â ãšã©ã¹ãã³æ§é ãšå èåãUV ã«ãã alternative splicingãsolar elastosis
- PMC10527789 · PMID 37759497 â Oh S et al., "High-Intensity Focused Ultrasound Increases Collagen and Elastin Fiber Synthesis by Modulating Caveolin-1 in Aging Skin", Cells 2023 â HIFU ã® Cav-1/ERK1/2 ã¡ã«ããºã ãType Iã»III ã³ã©ãŒã²ã³ã»ãšã©ã¹ãã³åæå¢å
- 確èªäºé : Type I ã³ã©ãŒã²ã³ã®å²åïŒ80ã90%ïŒãMMP é µçŽ ã¡ã«ããºã ãå èåçµè·¯ïŒROSã»MAPKã»NF-κBã»AP-1ïŒãsolar elastosis ã®å®çŸ©ãã¬ããã€ãã®æ ¹æ ãHIFU ã¡ã«ããºã ãåäººå·®ã®æèšãå ·äœçãªäŸ¡æ Œã»ç¹å®æœè¡ã®å¹ææå®ã»æç¶æéã®æå®ã¯äœ¿çšããŠããŸããã
- ãã¡ã¯ããã§ã㯠TODO: ïŒ1ïŒåœå ãŠã«ã»ã©ã»HIFU ã®éåœé£åå»è¬åå®å šåŠ(MFDS)æ¿èªåç®ã®åæç¢ºèªãå¿ èŠïŒæ¬èšäºã¯ã¡ã«ããºã æŠèгã®ã¿ â æ¿èªæå®ãªãïŒãïŒ2ïŒãªãžã¥ã©ã³(Rejuran) PN ã¡ã«ããºã ã®ææ°åºå ž PMC12429772 ã®è¿œå ã¯ãã¹ã¬ãã¥ãŒæšå¥šïŒæ¬èšäºã¯äžè¬æŠèгã¬ãã«ïŒãïŒ3ïŒã¬ããã€ãåŠæ¹ã«é¢ããéåœå æ¿èªè£œå€ãªã¹ãã¯ã«ãŠã³ã»ãªã³ã°åºæºã§äœ¿çšã
å»åŠçå
責äºé
æ¬ã³ã³ãã³ãã¯äžè¬çãªå¥åº·æ
å ±ã®æäŸãç®çãšããŠãããåå¥ã®èšºæã»æ²»çã«ã€ããŠã¯å¿
ãå°éå»ã«ãçžè«ãã ããã
ã»ãªããã¯å»é¢(Cellinique) ã«ãŠã³ã»ãªã³ã°ã»äºçŽ
ãœãŠã«ç¹å¥åžæ±ååºããµã³ãã228 ãšã³ã¹ã³ãã«ãã£ã³ã°
é»è©±: 02-6203-3434
蚺çæé: æãé 10:00ã19:00 / æ¯ææçµåææ¥ 10:00ã16:30

